A survey of new Rx, new generic, and new OTC products
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
FDA Approves Fremanezumab as First Anti-CGRP Drug for Prevention of Pediatric Episodic Migraine
The Current, Future Roles of AI within the Pharmacy Profession
FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B
The Unique Challenges, Growth in the Business of Health-System Pharmacy
FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1
FDA Approves Sebetralstat for Hereditary Angioedema